0 CHECKOUT

PRODUCT FILTERS

REGION

210
204
177
165
81

COUNTRY

164
14
13
11
10

CATEGORIES

  • 449
  • 142
  • 74
  • 61
  • 36
  • 18
  • 16
  • 15
  • 12
  • 12
  • 11
  • 10
  • 10
  • 10
  • 9
  • 8
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

291
567
657
944

PUBLISHED

11
31
268
944

PRODUCT TYPE

484
258
126
62
9
3
1
1

Search for: "Pfizer Inc.-Financial Company Report"

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to...

Published:  March 2016
Price:  From

Pfizer Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Pfizer Inc. Company Profile” is a comprehensive report on Pfizer Inc.. The report provides complete information on the operations, organization structure and financial information details of the company....

Published:  October 2014
Price:  From

Pfizer Inc (PFE: NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

Key Findings: - Unique new report provides deep financial benchmarks for (Pfizer Inc, PFE: NYS) compared to its top competitors and compared to the average for all companies within its primary industry. -...

Published:  October 2014
Price:  From

Pfizer Inc. - Strategy and SWOT Report

The Pfizer Inc. Company Profile is a professional and profound study that provides 360° analysis of the information on the operations, organization structure, financial details and competitor’s analysis...

Published:  December 2015
Price:  From

Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis

The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5 7% The fragmented market has observed some changes in the competitive landscape during the last...

Published:  December 2012
Price:  From

Strategic Importance of Intellectual Property (IP) in M&A

The report highlights strategic importance of intellectual property (IP) in Merger and acquisition (M&A) deals. The study analyzes recent IP-driven M&A deals, and pinpoints key role that IP assets and...

Published:  March 2015
Price:  From

Pfizer Inc. - Strategy and SWOT Report

Pfizer Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

Published:  February 2016
Price:  From

Immunotherapeutic Global Market - Forecast To 2021

Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the...

Published:  November 2015
Price:  From

Global Recombinant Coagulation Factors Market Outlook: 2015-2020

The global recombinant coagulation factors market has witnessed major growth over the past few years. The growth of this market is mainly due to increasing number of hemophilia patients, growing diagnosis...

Published:  November 2015
Price:  From

Penicillin and Streptomycin Market - Forecast 2015-2020

Penicillin and Streptomycin are two prominent drugs used in the treatment of diseases caused due to bacteria. Penicillin refers to a group of antibiotics such as Pencilillium V, Penicillium G. Penicillin...

Published:  December 2015
Price:  From

Research Update: Pfizer Inc. 'AA' Ratings Placed On CreditWatch Negative On Agreement To Acquire Allergan Nov 15

Abstract Pfizer Inc. announced today that it has agreed to acquire Allergan PLC in a roughly $160 billion equity-funded transaction. While the company will fund the acquisition with equity, we expect...

Published:  November 2015
Price: 

Vitamins and Nutrition supplements Market: By Vitamin (A, B, C, D, E and K) By Nutritional Supplements (Amino acids, Minerals, Probiotics, Others) End Users & By Geography - Forecast (2015 - 2020)

The increasing costs of healthcare products and the rise in health concerns of consumers are contributing to the growth of vitamin and nutritional supplements market. Increasing awareness on preventive...

Published:  December 2014
Price:  From

Bulletin: Pfizer Inc.'s Planned Acquisition Of Hospira Does Not Affect Ratings Feb 15

Abstract TORONTO (Standard & Poor's) Feb. 5, 2015--Standard & Poor's Ratings Services today said that New York City-based Pfizer Inc.'s announcement that it is acquiring Lake Forest, Ill.-based specialty...

Published:  February 2015
Price: 

Credit FAQ: How Does Standard & Poor's View Pfizer Inc.'s Proposed Merger With AstraZeneca? Apr 14

Abstract On April 29, 2014, Standard & Poor's Ratings Services said its ratings on New York-based Pfizer Inc. are unchanged at this time following Pfizer's proposal to merge with AstraZeneca in a deal...

Published:  April 2014
Price: 

Global Market Study on Osteoporosis Drugs: Asia Pacific to Witness Highest Growth by 2022

Osteoporosis is a progressive, skeletal disease, leading to fragile and abnormally porous bones. It is characterized by decrease in bone density, strength, and micro-architectural deterioration of bone...

Published:  June 2015
Price:  From

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered...

Published:  April 2014
Price:  From

Bulletin: Pfizer Inc. Ratings Unchanged Following U.S. Treasury Dept.'s Announcement On Inversion-Driven Mergers Apr 16

Abstract TORONTO (Standard & Poor's) April 5, 2016--Standard & Poor's Ratings Services said today that its ratings on Pfizer Inc. (AA/Watch Neg/A-1+) will remain on CreditWatch with negative implications...

Published:  April 2016
Price: 

Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020

About Post-Menopausal Vaginal Atrophy Drugs Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and...

Published:  April 2016
Price:  From

The US Specialty Pharmaceutical Market Report: 2015 Edition

Specialty pharmaceuticals are typically high-cost, scientifically engineered drugs used to treat complex, chronic conditions that require special storage, warranting special handling, and temperature-control...

Published:  March 2015
Price:  From

Icagen, Inc. - Product Pipeline Review - 2012

Icagen, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Icagen, Inc. - Product Pipeline Review - 2012” provides data on the Icagen, Inc.’s research and...

Published:  August 2012
Price:  From
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Western Union Company
  • Volvo Car Corporation
  • Morgan Stanley
  • SAP SE
  • LG Corporation
  • Roche Diagnostics Ltd.